Solid Biosciences
(NASDAQ:SLDB)
$13.32
-0.93[-6.53%]
At close: Mar 28
$13.32
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$5.00
Consensus Price Target1
$12.67

Solid Biosciences Stock (NASDAQ:SLDB), Analyst Ratings, Price Targets, Predictions

Solid Biosciences Inc has a consensus price target of $12.67, established from looking at the 22 latest analyst ratings. The last 3 analyst ratings were released from William Blair, Barclays, and Citigroup on March 28, 2024, March 18, 2024, and March 15, 2024. With an average price target of $25.67 between William Blair, Barclays, and Citigroup, there's an implied 92.69% upside for Solid Biosciences Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Dec 23
1
Mar
6
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

William Blair
Barclays
Citigroup
Piper Sandler
HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Solid Biosciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/28/2024SLDBBuy Now
Solid Biosciences
$13.32200.3%William Blair
Tim Lugo
→ $40Initiates → OutperformGet Alert
03/18/2024SLDBBuy Now
Solid Biosciences
$13.3257.66%Barclays
Gena Wang
$8 → $21MaintainsOverweightGet Alert
03/15/2024SLDBBuy Now
Solid Biosciences
$13.3220.12%Citigroup
David Hoang
→ $16Initiates → BuyGet Alert
03/14/2024SLDBBuy Now
Solid Biosciences
$13.3250.15%Piper Sandler
Allison Bratzel
$8 → $20UpgradeNeutral → OverweightGet Alert
03/14/2024SLDBBuy Now
Solid Biosciences
$13.3220.12%HC Wainwright & Co.
Arthur He
→ $16ReiteratesBuy → BuyGet Alert
03/11/2024SLDBBuy Now
Solid Biosciences
$13.3220.12%HC Wainwright & Co.
Arthur He
$9 → $16MaintainsBuyGet Alert
12/08/2023SLDBBuy Now
Solid Biosciences
$13.32-32.43%HC Wainwright & Co.
Swayampakula Ramakanth
→ $9Initiates → BuyGet Alert
09/22/2023SLDBBuy Now
Solid Biosciences
$13.32-62.46%Cantor Fitzgerald
Charles Duncan
→ $5Initiates → OverweightGet Alert
11/11/2022SLDBBuy Now
Solid Biosciences
$13.32-39.94%Barclays
Gena Wang
$2 → $8MaintainsOverweightGet Alert
11/11/2022SLDBBuy Now
Solid Biosciences
$13.32-39.94%Piper Sandler
Allison Bratzel
$15 → $8MaintainsNeutralGet Alert
11/10/2022SLDBBuy Now
Solid Biosciences
$13.32-54.95%SVB Leerink
Joseph Schwartz
$1 → $6MaintainsMarket PerformGet Alert
10/17/2022SLDBBuy Now
Solid Biosciences
$13.32-92.49%SVB Leerink
Joseph Schwartz
$180 → $15DowngradeOutperform → Market PerformGet Alert
09/30/2022SLDBBuy Now
Solid Biosciences
$13.32JP Morgan
Anupam Rama
UpgradeUnderweight → NeutralGet Alert
08/12/2022SLDBBuy Now
Solid Biosciences
$13.32-54.95%Chardan Capital
Geulah Livshits
$105 → $90MaintainsBuyGet Alert
05/19/2022SLDBBuy Now
Solid Biosciences
$13.32-84.98%Piper Sandler
Allison Bratzel
$75 → $30MaintainsNeutralGet Alert
04/28/2022SLDBBuy Now
Solid Biosciences
$13.32-62.46%Piper Sandler
Allison Bratzel
$90 → $75MaintainsNeutralGet Alert
04/28/2022SLDBBuy Now
Solid Biosciences
$13.3212.61%SVB Leerink
Joseph Schwartz
$180 → $225MaintainsOutperformGet Alert
04/28/2022SLDBBuy Now
Solid Biosciences
$13.32-47.45%Chardan Capital
Geulah Livshits
$255 → $105MaintainsBuyGet Alert
09/24/2021SLDBBuy Now
Solid Biosciences
$13.3227.63%Chardan Capital
Geulah Livshits
MaintainsBuyGet Alert

FAQ

Q

What is the target price for Solid Biosciences (SLDB)?

A

The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by William Blair on March 28, 2024. The analyst firm set a price target for $40.00 expecting SLDB to rise to within 12 months (a possible 200.30% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Solid Biosciences (SLDB)?

A

The latest analyst rating for Solid Biosciences (NASDAQ: SLDB) was provided by William Blair, and Solid Biosciences initiated their outperform rating.

Q

When was the last upgrade for Solid Biosciences (SLDB)?

A

The last upgrade for Solid Biosciences Inc happened on March 14, 2024 when Piper Sandler raised their price target to $20. Piper Sandler previously had a neutral for Solid Biosciences Inc.

Q

When was the last downgrade for Solid Biosciences (SLDB)?

A

The last downgrade for Solid Biosciences Inc happened on October 17, 2022 when SVB Leerink changed their price target from $12 to $1 for Solid Biosciences Inc.

Q

When is the next analyst rating going to be posted or updated for Solid Biosciences (SLDB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Solid Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Solid Biosciences was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.

Q

Is the Analyst Rating Solid Biosciences (SLDB) correct?

A

While ratings are subjective and will change, the latest Solid Biosciences (SLDB) rating was a initiated with a price target of $0.00 to $40.00. The current price Solid Biosciences (SLDB) is trading at is $13.32, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch